Vanguard Group Inc Exact Sciences Corp Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 17,020,290 shares of EXAS stock, worth $838 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,020,290
Previous 17,763,914
4.19%
Holding current value
$838 Million
Previous $1.21 Billion
20.93%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$864 Million0.16% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$594 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$594 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$307 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$284 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.72B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...